No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients
- PMID: 10720082
- DOI: 10.1210/jcem.85.3.6417
No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients
Abstract
Inhibition of tumor necrosis factor (TNF)-alpha results in a marked increase in insulin sensitivity in obese rodents. We investigated the influence of a TNF antagonist [Ro 45-2081, a recombinant fusion protein that consists of the soluble TNF-receptor (p55) linked to the Fc portion of human IgG1] on insulin sensitivity of patients with android obesity. Seven patients (five women and two men; mean +/- SD age, 41 +/- 4 yr; body mass index, 36.1 +/- 4.7 kg/m2; waist to hip ratio, 0.99 +/- 0.11) were studied (three patients with normal glucose tolerance and four patients with impaired glucose tolerance or mild diabetes; all were hyperinsulinemic). Each patient underwent two consecutive euglycemic hyperinsulinemic glucose-clamp tests: 48 h after injection of placebo and 48 h after a single i.v. injection of 50 mg Ro 45-2081. In both tests, steady-state plasma glucose and insulin levels were similar. Insulin-mediated glucose disposal (2.23 +/- 0.74 vs. 2.38 +/- 0.99 mg/kg(-1) x min(-1)) and glucose metabolic clearance rate (2.28 +/- 0.85 vs. 2.48 +/- 1.03 mL/kg(-1) x min(-1)) were similar after placebo and after the drug. Indirect calorimetry showed no difference in substrate oxidation rates between the two experimental conditions. In conclusion, under the conditions of this study, no improvement in insulin sensitivity was observed in obese insulin-resistant patients following a single i.v. administration of a recombinant TNF receptor: Fc fusion protein.
Similar articles
-
The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.Diabetes Care. 2007 Sep;30(9):2374-80. doi: 10.2337/dc07-0422. Epub 2007 Jun 26. Diabetes Care. 2007. PMID: 17595351
-
Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.Obes Res. 2003 Dec;11(12):1495-501. doi: 10.1038/oby.2003.200. Obes Res. 2003. PMID: 14694214
-
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.J Rheumatol. 2003 Oct;30(10):2123-6. J Rheumatol. 2003. PMID: 14528504 Clinical Trial.
-
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.J Rheumatol. 2003 Apr;30(4):680-90. J Rheumatol. 2003. PMID: 12672184 Clinical Trial.
-
Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.J Clin Endocrinol Metab. 2002 Oct;87(10):4602-6. doi: 10.1210/jc.2002-020135. J Clin Endocrinol Metab. 2002. PMID: 12364441
Cited by
-
Triptolide Administration Alters Immune Responses to Mitigate Insulin Resistance in Obese States.Biomolecules. 2024 Mar 25;14(4):395. doi: 10.3390/biom14040395. Biomolecules. 2024. PMID: 38672413 Free PMC article.
-
Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).Mol Med Rep. 2024 Jun;29(6):95. doi: 10.3892/mmr.2024.13219. Epub 2024 Apr 12. Mol Med Rep. 2024. PMID: 38606791 Free PMC article. Review.
-
Myeloid-derived grancalcin instigates obesity-induced insulin resistance and metabolic inflammation in male mice.Nat Commun. 2024 Jan 2;15(1):97. doi: 10.1038/s41467-023-43787-x. Nat Commun. 2024. PMID: 38167327 Free PMC article.
-
Unraveling the complex roles of macrophages in obese adipose tissue: an overview.Front Med. 2024 Apr;18(2):205-236. doi: 10.1007/s11684-023-1033-7. Epub 2024 Jan 2. Front Med. 2024. PMID: 38165533 Review.
-
White adipocyte dysfunction and obesity-associated pathologies in humans.Nat Rev Mol Cell Biol. 2024 Apr;25(4):270-289. doi: 10.1038/s41580-023-00680-1. Epub 2023 Dec 12. Nat Rev Mol Cell Biol. 2024. PMID: 38086922 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous